Infographic | March 28, 2022

Oligonucleotide Development And Manufacturing Workflow

Source: Cytiva

Oligonucleotides (or oligos) are synthetic strands of DNA or RNA that can be used as therapies or diagnostics by binding to a target gene or protein sequence. The fast-growing oligo therapeutics market includes highly targeted antisense DNA and small interfering RNA (siRNA), and it is growing in promise for treating cancers, genetic diseases, and other conditions, as new applications, like CRISPR are being discovered.

Learn more about oligo workflows and solutions for oligonucleotide process development, from scalable oligo synthesis to cleavage and deprotection, purification, and buffer exchange.

access the Infographic!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Discovery Online